Monitor the investigation's progress through the target date and any early settlement or ALJ initial determination. The outcome could affect Cytek's competitive position in spectral flow cytometry if exclusion orders are issued against Beckman Coulter's products.
Price Chart
Executive Summary
The USITC instituted Investigation No. 337-TA-1528 based on a complaint by Cytek Biosciences, Inc. alleging that Beckman Coulter, Inc. and its affiliate infringe three Cytek patents covering spectral flow cytometry systems and components. The investigation is at an early stage; no determination on the merits has been made.
ITC Section 337 Details
Key Facts
- Investigation No. 337-TA-1528 was instituted on November 10, 2026, based on a complaint filed October 8, 2026 by Cytek Biosciences, Inc.
- The accused products are spectral flow cytometry systems and components, including respondents' 'mosaic 88 and mosaic 63 products'.
- Three patents are asserted: U.S. Patent Nos. 12,754,128; 12,487,167; and 10,739,245.
- Respondents are Beckman Coulter, Inc. and Beckman Coulter Biotechnology (Suzhou) Co., Ltd.
- Cytek requests a limited exclusion order and cease and desist orders.
Financial Impact
Not quantifiable at institution stage; no damages or settlement amounts stated.
Risk Factors
- Institution of investigation is an early procedural step; no violation has been found.
- Beckman Coulter may contest the patent claims and domestic industry allegations.
- The investigation could take 15-18 months to reach a final determination.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 USITC notice.
| Document | Accession Number |
|---|---|
| ITC-337 Data (Synthetic) | itc-2026-23254-CTKB |
Track record
14 reports on CTKB
1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +1.49% at T+1 after the Jun 11, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago ITC Section 337 Neutral 3/10 Viewing Entry $5.78 Now $5.63 −2.60% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $5.84 to $5.63 Now $5.63 −3.60% ▼ −3.60% −1.68% vs SPY
- Nov 10, 20266d ago Institutional Cluster Bullish 4/10 Entry $5.79 to $5.76 Now $5.63 −2.76% ▼ −0.52% −1.84% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $5.40 to $5.83 Now $5.63 +4.26% ▲ +7.96% +7.65% vs SPY
- Nov 3, 202613d ago SC 13G/A Neutral 2/10 Entry $5.88 to $5.40 Now $5.63 −4.25% ▼ −8.16% −3.75% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $5.43 to $5.59 Now $5.63 +3.68% ▲ +2.95% +3.47% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $5.71 to $5.68 Now $5.63 −1.40% ▼ −0.53% +0.19% vs SPY
- Aug 24, 202612w ago 8-K Bearish 7/10 Entry $4.44 to $4.58 Now $5.63 −26.80% ▼ −3.15% −2.83% vs SPY
- Jun 25, 202620w ago 8-K Neutral 2/10 Entry $4.48 to $4.34 Now $5.63 +25.67% ▼ −3.13% −4.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time ITC Section 337 Intelligence
Market-moving USITC Section 337 notices analyzed within minutes. Complaints, exclusion orders, final determinations, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers